Biotech

All Articles

Galapagos pauses CAR-T cell treatment hearing over Parkinsonism case

.Galapagos has stopped briefly enrollment in a trial of a BCMA-directed CAR-T tissue treatment, push...

James Wilson leaving behind Penn to introduce pair of brand-new biotechs

.After more than thirty years, gene treatment innovator James Wilson M.D., Ph.D., is actually leavin...

3 biotechs try to beat the summer heat energy by dropping staff

.As biotechs seek to transform a fresh page in August, at the very least 3 business have actually sh...

venBio lifts $528M for fifth life scientific researches VC fund

.Veteran venture capital agency venBio has elevated yet another half a billion bucks to acquire biot...

Otsuka pays out $800M for Jnana as well as its clinical-stage PKU medicine

.Otsuka Pharmaceutical has grabbed Boston-based Jnana Therapeutics for $800 thousand so the Japanese...

FibroGen lays off 75% people staff as resource flunks 2 more trials

.FibroGen is actually radically restructuring its own company, giving up 75% of its own united state...

Tracon winds down full weeks after injectable PD-L1 inhibitor fall short

.Tracon Pharmaceuticals has made a decision to unwind procedures full weeks after an injectable immu...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M package

.Ideaya Biosciences is actually wagering $400 million in biobucks that a bispecific antibody-drug co...

Takeda takes $140M reduction on neglected epilepsy medication, proclaims FDA operate

.Our experts presently know that Takeda is hoping to discover a course to the FDA for epilepsy medic...

VBI Vaccines files for insolvency, seeks possession purchase

.Immunology biotech VBI Injections is actually drifting hazardously near to the defining moment, wit...